Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2020-04-28 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1355 characters) and explicitly states it is an 'RNS Number' announcement from the London Stock Exchange regarding a 'Price Monitoring Extension' for a security. It describes a temporary trading mechanism adjustment rather than a comprehensive financial report, management change, or shareholder vote result. Since it is a general regulatory announcement provided via the RNS service and does not fit any of the more specific categories (like DIV, ER, 10-K, etc.), the most appropriate classification is the general regulatory fallback category.
2020-04-28 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1355 characters) and announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange, identified by the 'RNS Number : 9426K'. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates a general regulatory announcement that does not fit the specific financial report categories (like 10-K, ER, IR) or specific corporate actions (like DIV, DIRS, MANG). Therefore, the most appropriate classification is the general regulatory announcement fallback category.
2020-04-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document explicitly states 'RNS Number : 8537K' and 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS is the standard identifier for regulatory news service announcements in the UK. The content is a 'TR-1: Standard form for notification of major holdings,' which details changes in share ownership thresholds by a shareholder (SPREADEX LTD). This type of filing, reporting changes in significant shareholdings, directly maps to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content is a major holding notification, making MRQ the most precise classification over the general RNS fallback.
2020-04-24 English
Distribution agreement for AIHL test
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 7231K' and is dated April 24, 2020. It announces a contract for the distribution of a medical test between two companies. The presence of the RNS Number and the nature of the announcement (a business development/contract signing) strongly suggest this is a regulatory news service release. Since it is a general business announcement that doesn't fit specific categories like M&A (TAR), Director's Dealing (DIRS), or Dividend (DIV), the most appropriate classification is the general regulatory filing category, RNS.
2020-04-24 English
Appointment of Joint Broker
Regulatory Filings Classification · 1% confidence The document is identified by the header "RNS Number : 3949K" and explicitly mentions that the information is provided by RNS, the news service of the London Stock Exchange, which is approved by the Financial Conduct Authority (FCA) as a Primary Information Provider. The content itself is a brief announcement regarding the 'Appointment of Joint Broker'. This type of immediate, non-periodic, and general regulatory disclosure that doesn't fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified under the general regulatory announcement category. Given the options, RNS (Regulatory Filings) is the most appropriate fallback for a standard regulatory news service announcement.
2020-04-22 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1372 characters) and explicitly states it is providing 'Additional information' via an 'RNS Number'. The content discusses a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a general regulatory announcement concerning trading mechanics rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement distributed via RNS, the most appropriate classification is Regulatory Filings (RNS), as it doesn't fit the more specific categories like DIV, DIRS, or CAP.
2020-04-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.